Ornopia, Vanessa Mae T.
HRN: 00-47-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2024
CEFUROXIME 1.5GM (VIAL)
08/04/2024
08/04/2024
IV
1.5gms
Q8
UTI
Waiting Final Action
Indication: EmpiricEmpirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes